Hudson Bay Capital Management »

Aclaris Therapeutics shares owned by Hudson Bay Capital Management

Quarter-by-quarter ownership of Aclaris Therapeutics (ACRS) shares owned by Hudson Bay Capital Management from 13F filings

Historical chart of Hudson Bay Capital Management investment in Aclaris Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Aclaris Therapeutics held by Hudson Bay Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aclaris Therapeutics by Hudson Bay Capital Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $63k 17k 3.75
2025-03-31 $19k 12k 1.53

More positions owned by Hudson Bay Capital Management

NVIDIA Corporation Call Option (NVDA)
Tesla Motors Call Option (TSLA)
Amazon Call Option (AMZN)
Apple Call Option (AAPL)
Palantir Technologies Cl A Call Option (PLTR)
Netflix Call Option (NFLX)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Advanced Micro Devices Call Option (AMD)
State Str Spdr S&p 500 Etf T Tr Unit Call Option (SPY)
Berkshire Hathaway Inc Del Cl B New Put Option (BRK.B)
Microsoft Corporation Call Option (MSFT)
Echostar Corp Note 3.875%11/3 (Principal)
Taiwan Semiconductor Manufac Sponsored Ads Put Option (TSM)
Flagstar Bank National Assoc Com New (FLG)
UnitedHealth Put Option (UNH)

View all positions for Hudson Bay Capital Management

Top funds holding Aclaris Therapeutics

BML Capital Management
Deep Track Capital
BlackRock
RA Capital Management
Vivo Capital
Vanguard Group
Vanguard Capital Management
Frazier Life Sciences Management
Rock Springs Capital Management
Decheng Capital
Adage Capital Partners GP
Balyasny Asset Management
Citadel Advisors
Morgan Stanley
Geode Capital Management

View all funds holding Aclaris Therapeutics